TCRT
Alaunos Therapeutics Inc
NASDAQ: TCRT · HEALTHCARE · BIOTECHNOLOGY
$2.55
-0.39% today
Updated 2026-04-30
Market cap
$6.16M
P/E ratio
—
P/S ratio
1,231.94x
EPS (TTM)
$-2.20
Dividend yield
—
52W range
$2 – $5
Volume
0.0M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F4.8
Quality
C2.5
Profitability
F6.0
Valuation
B2/9
Piotroski F-Score
Weak
-470.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$1.75
-31.37%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -470.12 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-553000.00
- Revenue declining -25.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.92M | $5000.00 | $10000.00 | $5000.00 | $5000.00 |
| Net income | $-37.73M | $-35.14M | $-4.68M | $-4.18M | $-893000.00 |
| EPS | — | — | — | — | $-2.20 |
| Free cash flow | $-29.45M | $-30.34M | $-4.97M | $-2.97M | $-553000.00 |
| Profit margin | -1,291.24% | -702,800.00% | -46,790.00% | -83,520.00% | — |
Peer comparison
Smart narrative
Alaunos Therapeutics Inc trades at $2.55. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -470.12, it sits in the distress. TTM revenue stands at $5000.00.
Frequently asked questions
What is Alaunos Therapeutics Inc's stock price?
Alaunos Therapeutics Inc (TCRT) trades at $2.55.
Is Alaunos Therapeutics Inc overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell).
What is the price target of Alaunos Therapeutics Inc (TCRT)?
The analyst target price is $1.75, representing -31.4% downside from the current price of $2.55.
What is Alaunos Therapeutics Inc's revenue?
TTM revenue is $5000.00.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-470.12 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1,231.94x
ROE-198.10%
Beta-1.13
50D MA$3.02
200D MA$2.93
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—